Core Scientific (CORZ) Preferred Stock Liabilities (2020 - 2021)

Core Scientific has disclosed Preferred Stock Liabilities across 2 years of filings, most recently posting $44.5 million for Q4 2021.

• In Q4 2021, Preferred Stock Liabilities changed 0.0% year-over-year to $44.5 million; the TTM figure through Dec 2021 stood at $44.5 million (changed 0.0% YoY), while the FY2021 annual figure was $44.5 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities came in at $44.5 million for Q4 2021 at Core Scientific, down from $345.0 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $345.0 million in Q3 2021 to a low of $44.5 million in Q4 2020.